您的位置: 首页 > 农业专利 > 详情页

COMPOSITION PHARMACEUTIQUE DESTINEE A PREVENIR UNE DEPENDANCE AUX OPIOIDES
专利权人:
INC.;REGENERON PHARMACEUTICALS
发明人:
STEHMAN-BREEN, CATHERINE,DAVIS, JOHN
申请号:
CA3045116
公开号:
CA3045116A1
申请日:
2017.11.28
申请国别(地区):
CA
年份:
2018
代理人:
摘要:
A pharmaceutical composition for averting opioid addiction in a patient is disclosed. The composition can be used in a patient suffering from moderate to severe low back pain (LBP). The composition is useful in a patient diagnosed with low back pain, and comprises a therapeutically effective amount of an antibody that binds specifically to nerve growth factor (NGF) or an antigen binding fragment thereof; and is used in the absence of an opioid to relieve pain, and avert opioid addiction in a patient.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充